Bill

Bill > A03048


NY A03048

NY A03048
Includes nurse practioners as a provider of services for purposes of collaborative drug therapy management and makes the authorization for pharmacists to perform such management permanent.


summary

Introduced
01/28/2019
In Committee
01/08/2020
Crossed Over
Passed
Dead
12/31/2020

Introduced Session

2019-2020 General Assembly

Bill Summary

AN ACT to amend the education law, in relation to including nurse practitioners as a provider of services for purposes of collaborative drug therapy management; and to amend chapter 21 of the laws of 2011 amending the education law relating to authorizing pharmacists to perform collaborative drug therapy management with physicians in certain settings, in relation to making the authorization for pharmacists to perform collaborative drug therapy management permanent The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1

AI Summary

This bill expands the collaborative drug therapy management program in New York to include nurse practitioners as providers, in addition to physicians. It also makes the authorization for pharmacists to perform such collaborative drug therapy management permanent, rather than having it expire. The bill defines key terms like "collaborative drug therapy management," "facility," and "physician or nurse practitioner," and outlines the requirements for pharmacists to participate in the program, including certain educational and experience credentials. The bill maintains that participation in the program is voluntary for patients, pharmacists, physicians, and nurse practitioners.

Committee Categories

Education

Sponsors (5)

Last Action

referred to higher education (on 01/08/2020)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...